Autogenous Vaccines Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
The global autogenous vaccines market was estimated to be US$ 130.4 Million in 2022 and is expected grow at a CAGR of 5.2% between 2023 to 2032.
Autogenous vaccines, also known as autovaccines, are vaccines made from a specific pathogen that is isolated from an animal, cultured, and then inactivated or attenuated to create a vaccine. These vaccines are custom-made for a particular animal or herd and are designed to treat or prevent infections that are difficult to manage with traditional vaccines.
Autogenous vaccines are typically used in situations where commercial vaccines are ineffective, unavailable, or insufficient in addressing a particular disease outbreak. They are commonly used in livestock, poultry, and aquaculture industries.
Autogenous Vaccines Market Drivers
Increasing demand for animal-derived food products is boosting the market growth
The global autogenous vaccines market is driven by several factors, including the increasing demand for animal-derived food products and concerns about animal health. With the growing global population, the demand for meat, milk, and eggs is increasing, making animal health a crucial factor for industry.
Healthy animals are more productive and provide higher quality products. Moreover, the growing prevalence of zoonotic and other animal-related diseases is a growing concern globally, and vaccines are essential tools for preventing their spread.
The market is also driven by increasing government initiatives and support for animal health and welfare. Many governments are investing in animal health and welfare programs as part of their efforts to ensure food security, public health, and economic growth. Additionally, technological advancements in vaccine development and production techniques are leading to the development of more effective and efficient vaccine production methods.
For example, DNA vaccines are a newer type of vaccine that uses genetic material to stimulate an immune response, which shows promising results in preventing various diseases. Overall, these factors are contributing to the growth of the global autogenous vaccines market, which is expected to continue in the future.
Strain type segmentation of Global Autogenous Vaccines Market
Virus-strain autogenous vaccines play an important role in the industry
Based on the strain type, the market is segmented into Bacterial Strain, and Virus Strain.
Among these, the bacterial strain segment has been larger than the virus strain segment. This is because bacterial infections are more prevalent in the animal population and are often more severe than viral infections. Bacterial infections can cause a range of diseases, such as pneumonia, mastitis, and enteritis, that can significantly impact animal health and productivity. As a result, vaccines for bacterial strains are in higher demand, particularly for species like cattle, pigs, and poultry.
Moreover, bacterial strains can be more easily isolated and cultured than virus strains, which makes it easier to develop autogenous vaccines against bacterial infections. In contrast, virus strains are more complex and difficult to isolate and culture, which can make vaccine development more challenging and time-consuming.
The market for virus strain autogenous vaccines is also significant and growing, as viral diseases such as foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS) continue to pose significant threats to animal health and food security.
Overall, both bacterial and virus strain autogenous vaccines play an important role in the global animal health industry, and their market sizes can vary depending on several factors such as the prevalence of diseases, technological advancements, and government policies.
End-use segmentation of Global Autogenous Vaccines Market
Veterinary clinics segment is the largest in the autogenous vaccines market
Based on the end-use, the market is segmented into Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, and other end-users.
Among these, the veterinary clinics segment is the largest in the autogenous vaccines market due to several factors. Veterinary clinics are the primary point of care for most pets and farm animals, making them an essential part of the animal health industry.
Autogenous vaccines are frequently used in veterinary clinics to prevent and treat bacterial and viral infections, making them an essential product for these facilities. Additionally, the increasing demand for animal-derived food products has led to the growth of the livestock industry, which relies on veterinary clinics for animal health services.
The fastest-growing segment in the autogenous vaccines market is the veterinary research institutes segment. These institutes are focused on researching and developing new vaccines and treatments for animal diseases. Autogenous vaccines are a crucial tool for these institutes as they allow researchers to customize vaccines to specific animal populations and disease outbreaks.
Additionally, the increasing prevalence of zoonotic diseases and other animal-related diseases has led to a growing demand for research into new vaccines and treatments. The veterinary research institutes segment is expected to continue to grow rapidly as the demand for new and more effective animal health products increases.
Regional trends of the Global Autogenous Vaccines Market
North American autogenous vaccine market focuses on animal health and welfare
Geographically, the global autogenous vaccines market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
Following are some of the major trends in these regions –
North America: The North American autogenous vaccines market is well-established, with a significant focus on animal health and welfare. The region is home to several major players in the market, investing in research and development to produce more effective and efficient autogenous vaccines for various animal diseases prevalent in the region.
The region's animal husbandry industry includes dairy, beef, swine, and poultry production, contributing to the market's growth. Additionally, the increasing prevalence of zoonotic diseases, such as Avian Influenza and West Nile virus, has contributed to the growth of the autogenous vaccines market in the region.
Europe: Europe is a significant contributor to the global autogenous vaccines market, with countries such as Germany, France, and the UK being major players in the market. The region's focus on animal welfare and food safety has contributed to the growth of the market.
The region's animal husbandry industry includes dairy, beef, swine, and poultry production, contributing to the market's growth. Additionally, the increasing prevalence of diseases such as bovine mastitis, porcine circovirus, and foot-and-mouth disease has driven the demand for autogenous vaccines in the region.
Asia-Pacific: The Asia-Pacific region is expected to witness significant growth in the coming years, driven by the increasing demand for animal-derived food products and the growing focus on animal health and welfare in countries such as China and India.
The region's animal husbandry industry includes dairy, beef, swine, and poultry production, contributing to the market's growth. Additionally, the increasing prevalence of diseases such as avian influenza and African swine fever has driven the demand for autogenous vaccines in the region.
Key players and market strategies:
Companies operating in the global autogenous vaccines market are adopting various growth strategies to strengthen their market position and increase their market share. One of the primary growth strategies adopted by companies is expanding their product portfolio by investing in research and development activities to develop new and more effective autogenous vaccines for various animal diseases.
Companies are also focusing on collaborations and partnerships to leverage their expertise and capabilities, expand their geographic presence, and enhance their product offerings.
Another key growth strategy adopted by companies is mergers and acquisitions to acquire new technologies and expertise, expand their market share, and increase their customer base. Additionally, companies are focusing on increasing their production capacity to meet the growing demand for autogenous vaccines.
Moreover, companies are also investing in marketing and promotional activities to create awareness among consumers about the benefits of autogenous vaccines and increase their market penetration.
Overall, companies operating in the global autogenous vaccines market are adopting a combination of strategies to strengthen their market position, expand their product portfolio, and increase their market share.
With the increasing demand for animal-derived food products and the growing prevalence of zoonotic diseases, the market for autogenous vaccines is expected to witness significant growth, and companies are expected to continue to adopt various growth strategies to capitalize on the market opportunities.
Some of the biggest companies operating in the global autogenous vaccines market are Agrovet Market Animal Health, Bioveta a.s., Ceva Santé Animale, HIPRA, Hygieia Biological Laboratories, Indian Immunologicals Limited, Inovio Pharmaceuticals, Merck Animal Health, Neogen Corporation, Pfizer Animal Health, Phibro Animal Health Corporation, TechMix Global, Virbac, Zoetis, and many more.
Global Autogenous Vaccines Market Segmentation:
By Strain Type:
- Bacterial Strain
- Virus Strain
By End-use:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
By Region:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Autogenous Vaccines Market
- Global Autogenous Vaccines Market Qualitative Analysis
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Trends
- Global Autogenous Vaccines Market Analysis and Forecast, by Strain Type
- Overview and definitions
- Key segment analysis
- Global Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- Global Autogenous Vaccines Market Analysis and Forecast, by End Use
- Overview and definitions
- Key segment analysis
- Global Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- Global Autogenous Vaccines Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Autogenous Vaccines Market Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Autogenous Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- North America Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- North America Autogenous Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
- United States
- Canada
- Rest of North America
- Europe Autogenous Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- Europe Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- Europe Autogenous Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific Autogenous Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- Asia Pacific Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- Asia Pacific Autogenous Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
- China
- Japan
- South Korea
- India
- Australia
- Rest of Asia Pacific
- Middle East & Africa Autogenous Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- Middle East & Africa Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- Middle East & Africa Autogenous Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America Autogenous Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Autogenous Vaccines Market Estimates (US$ Mn), Strain Type, 2019 – 2032
- Bacterial Strain
- Virus Strain
- South America Autogenous Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- South America Autogenous Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
- Brazil
- Argentina
- Rest of South America
- Competition Analysis – Global Autogenous Vaccines Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- Agrovet Market Animal Health
- Business overview
- Geographic presence
- Product portfolio
- Financial facts
- Relevant news and strategic view
- Bioveta a.s.
- Ceva Santé Animale
- HIPRA
- Hygieia Biological Laboratories
- Indian Immunologicals Limited
- Inovio Pharmaceuticals
- Merck Animal Health
- Neogen Corporation
- Pfizer Animal Health
- Phibro Animal Health Corporation
- TechMix Global
- Virbac
- Zoetis
- Agrovet Market Animal Health
- Conclusion & Recommendations
Frequently asked questions about this report
How much is the autogenous vaccines market worth?
The autogenous vaccines market was estimated to be US$ 130.4 Million in 2022.
What is the autogenous vaccines market growth?
The autogenous vaccines market is expected grow at a CAGR of 5.2% between 2023 to 2032.
What are the key drivers for the global autogenous vaccines market?
The global autogenous vaccines market is driven by several factors, including the increasing demand for animal-derived food products and concerns about animal health. With the growing global population, the demand for meat, milk, and eggs is increasing, making animal health a crucial factor for industry.
Which strain type is significant and growing in the autogenous vaccines market?
The market for virus strain autogenous vaccines is also significant and growing, as viral diseases such as foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS) continue to pose significant threats to animal health and food security.
Which end-use type is the fastest-growing in the autogenous vaccines market?
The fastest-growing segment in the autogenous vaccines market is the veterinary research institutes segment. These institutes are focused on researching and developing new vaccines and treatments for animal diseases.
Which is the largest market for autogenous vaccines?
North America is the largest market for autogenous vaccines. The region is home to several major players in the market, investing in research and development to produce more effective and efficient autogenous vaccines for various animal diseases prevalent in the region.
Which are leading players in the autogenous vaccines market?
Agrovet Market Animal Health, Bioveta a.s., Ceva Santé Animale, HIPRA, Hygieia Biological Laboratories, Indian Immunologicals Limited, Inovio Pharmaceuticals, Merck Animal Health, Neogen Corporation, Pfizer Animal Health, Phibro Animal Health Corporation, TechMix Global, Virbac, Zoetis among others, are the leading players in this autogenous vaccines market.